Portola Pharmaceuticals Inc (PTLA) Return on Investment ROI from the first quarter of 2020 to first quarter of 2019 and for the year 2020, average high and low, overall ranking from Mar 31 2020 to Mar 31 2019 - CSIMarket
CSIMarket Company Name, Ticker, Customers, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Portola Pharmaceuticals inc   (NASDAQ: PTLA)


Portola Pharmaceuticals Inc's ROI from its first quarter of 2020 to the first quarter of 2019 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Portola Pharmaceuticals Inc's ROI in the first quarter of 2020?
Portola Pharmaceuticals Inc recorded a cumulative net loss of $-284 million during 12 months ending in the first quarter of 2020, resulting in a negative return on investment (ROI) of -70.63%.

Within the Healthcare sector 550 other companies had a higher return on investment. While return on investment, the total ranking has deteriorated compared to the fourth quarter of 2019 from 0 to 4020.

Definition and Formula of Return on Investment


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Investment (Mar 31 2020)
I. Quarter		 (Dec 31 2019)
IV. Quarter		 (Sep 30 2019)
III. Quarter		 (Jun 30 2019)
II. Quarter		 (Mar 31 2019)
I. Quarter
Y / Y Investment Change TTM 21.13 % 4.42 % -28.44 % -40.07 % -21.42 %
Y / Y Net Income Change TTM - - - - -
Investment (TTM) in Millions 433 401 490 282 329
Return On Investment (TTM) -70.63 % -78.01 % -90.15 % -105.33 % -103.84 %
PTLA's Overall Ranking # 4020 # 0 # 0 # 0 # 0
Seq. Investment Change TTM 6.93 % 18.72 % 8.64 % -12.16 % -7.83 %
Seq. Net Income Change TTM - - - - -
Net Income (TTM) in Millions -284 -293 -285 -307 -344

PTLA Company Profile >> Back to PTLA Roi Comparisons >> See Annual PTLA Return On Investment



Return On Investment PTLA's Ranking
Within: No.
Industry # 257
Sector # 551
Overall # 4020

Return On Investment Statistics
High Average Low
-46.5 %
-68.89 %
-92.52 %
(Mar 31 2015)   (Mar 31 2019)







Financial Statements
Portola Pharmaceuticals Inc's I. Quarter Investments $ 433 Millions PTLA's Balance sheet
Portola Pharmaceuticals Inc's I. Quarter Income $ -69 Millions Quarterly PTLA's Income Statement
PTLA's Income by Division See PTLA's Income by Division


PTLA Annual Return On Investment (Dec 31 2019)
2019		 (Dec 31 2018)
2018		 (Dec 31 2017)
2017		 (Dec 31 2016)
2016		 (Dec 31 2015)
2015
Total Investments in Millions 476 320 494 272 455
Y / Y Investment Growth 48.97 % -35.28 % 81.58 % -40.2 % 21.14 %
Net Income in Millions -293 -351 -286 -268 -227
Y / Y Net Income Growth - - - - -
Annual Return On Investment -61.52 % -109.69 % -57.84 % -98.6 % -49.81 %


Annual Roi Comment


Definition and Formula of Return on Investment

Other ROI Ratios
Major Pharmaceutical Preparations Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
PTLA's Roi Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for PTLA's Competitors
Subscribers only: Roi for Portola Pharmaceuticals Inc's Suppliers
Subscribers only: Return On Investment for PTLA's Customers

Other Ratios
PTLA's Roa PTLA's Inventory Turnover Ratio PTLA's Growth Rates PTLA's Dividend Statistics
PTLA's Profitability Ratios PTLA's Asset Turnover Ratio PTLA's Dividend Growth
PTLA's Roe PTLA's Valuation Ratios PTLA's Financial Strength Ratios PTLA's Dividend Payout Ratio



Companies with similar Return On Investment at Mar 31 2020, within Healthcare Sector ROI

Date modified: 2026-09-08T15:09:56+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.